We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Dr
Aygul
Dagbasi
+44 7708369942
a.dagbasi16@imperial.ac.uk
Prof
Gary
Frost
+44 (0)20 7594 0959
g.frost@imperial.ac.uk
Mrs
Monica
Hill
+44 7340626852
m.mischie18@imperial.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Healthy individuals at risk of developing non-communicable diseases (heart disease, type 2 diabetes, cancer).
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Unhealthy diets are associated with metabolic changes and increased risk of non-communicable diseases (NCDs). However, current understanding of the relationship between diet and the development of NCD is limited by a number of factors. These include a lack of understanding of dietary mechanisms that drive NCD, inaccurate tools to collect dietary information, a nascent understanding of the role of personalised nutrition, and the lack of data in vulnerable groups where NCDs are often over-represented.
The relationship between dietary intake and the development of NCD is complex. The understanding of how diet relates to the development of metabolic risk factors on a background of non-modifiable risk factors is improving with the greater understanding of the metabolic pathways that are responsive to dietary profile and lead to change in NCD risk. Tools that profile the genome, metabolome, epigenome, microbiome, and inflammation are key to understanding the impact of diet on NCDs. However, these systems are mostly studied in isolation and their relative importance of how they interact with each other is not understood.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
You can take part if:
You may not be able to take part if:
1. Suffer from the following conditions: type 2 diabetes, chronic gastrointestinal conditions (Crohn’s disease, irritable bowel syndrome, ulcerative colitis etc.), acute infectious diseases, cardiovascular diseases, hypertension, autoimmune conditions, 2. Were on antibiotic treatment in the 12 weeks preceding enrolment of the clinical trial, 3. Pregnant or currently breastfeeding, 4. Are currently participating in other clinical trials or participated in another trial within the last 12 weeks, 5. Require any medical interventions during the study period, 6. Cannot give consent by yourself.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Mrs
Monica
Hill
+44 7340626852
m.mischie18@imperial.ac.uk
Dr
Aygul
Dagbasi
+44 7708369942
a.dagbasi16@imperial.ac.uk
Prof
Gary
Frost
+44 (0)20 7594 0959
g.frost@imperial.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by Imperial College London and funded by UK Research and Innovation; European Union Horizon Programme.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 59206
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
